Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Fortress Biotech (FBIO) over the last 8 years, with Q3 2025 value amounting to $0.11.

  • Fortress Biotech's EPS (Weighted Average and Diluted) rose 11447.37% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year increase of 9411.76%. This contributed to the annual value of -$2.69 for FY2024, which is 6825.21% up from last year.
  • Latest data reveals that Fortress Biotech reported EPS (Weighted Average and Diluted) of $0.11 as of Q3 2025, which was up 11447.37% from $0.45 recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's EPS (Weighted Average and Diluted) peaked at $0.45 during Q2 2025, and registered a low of -$4.82 during Q4 2022.
  • For the 5-year period, Fortress Biotech's EPS (Weighted Average and Diluted) averaged around -$0.97, with its median value being -$0.46 (2024).
  • As far as peak fluctuations go, Fortress Biotech's EPS (Weighted Average and Diluted) plummeted by 148076.92% in 2022, and later soared by 16164.38% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's EPS (Weighted Average and Diluted) stood at -$0.38 in 2021, then plummeted by 1168.42% to -$4.82 in 2022, then surged by 89.0% to -$0.53 in 2023, then grew by 12.38% to -$0.46 in 2024, then skyrocketed by 123.69% to $0.11 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.11 in Q3 2025, compared to $0.45 in Q2 2025 and -$0.48 in Q1 2025.